Haukaas, Fredrik Salvesen
Ohna, Audun
Krivasi, Tania
Funding for this research was provided by:
F. Hoffmann-La Roche
Article History
First Online: 19 June 2018
Compliance with Ethical Standards
:
: Both GADOLIN and the present study were funded by F. Hoffman-La Roche.
: Fredrik Salvesen Haukaas, Audun Ohna and Tania Krivasi are employees of F. Hoffmann-La Roche, which markets obinutuzumab (Gazyvaro®).